2022 Revenues ($USD) : $428,458,000
2022 Revenues (foreign currencies) : € 363,100,000
2022 R&D spend : $13,341,080
2022 Number of Employees : 1,341
Fiscal Year End : 12/31/2021
Company CEO : Francesco Siccardi, CEO

Founded in 1999, Switzerland-based Medacta is active in joint replacement, spine surgery and sports medicine. It started with minimally invasive surgical techniques and evolved into offerings personlized for each patient. It operates in more than 40 countries. –CN